جست‌وجوی استاد و پژوهشگر

Kiersten Simmonsمشاهده پروفایل

پژوهشگر ارشد

• Healthcare inequity
• Women's health
• Sexual Health
• +۴ مورد دیگر

Kiersten Simmons serves as a Medical Doctoral Fellow (Research Fellow) at Brighton and Sussex Medical School (BSMS), where she bridges clinical practice as an HIV/sexual health physician with research leadership. She concurrently chairs two major research networks: the Kent, Surrey, and Sussex Women’s Health Research Network Group and the Coastal Communities Research Network Group (Sussex), driving community-engaged health equity initiatives across Southeast England. Her research portfolio centers on healthcare inequity with specific focus areas including: Women's health access for midlife women (40-65 years) HIV care across diverse populations Coastal community health disparities Implementation science through co-production methodologies Her current PhD investigates sexual health service barriers in underserved East Sussex communities using mixed-methods approaches with active Patient Participant Involvement. Recent publications (2024-2025) demonstrate a clear trajectory toward qualitative studies of women's health access, complemented by systematic reviews of international evidence. Her HIV-related work maintains clinical relevance through studies on vaccination impacts, pregnancy management, and departmental wellbeing. Scientific recognition includes: British HIV Association Research Award (2024, £7,755) for midlife women's HIV research British HIV Association Implementation Science Scholarship (2019, £2,700) for frailty studies in aging HIV populations Dr. Simmons secures targeted research funding while maintaining active NHS clinical practice. Her teaching spans undergraduate medical education to the BSMS Global Health Masters program, consistently integrating social determinants of health frameworks. She champions interdisciplinary collaboration through her research networks, which serve as platforms for community-driven health equity solutions. Her leadership of the Kent, Surrey, and Sussex Women’s Health Research Network Group enables large-scale co-produced projects like The POWER: East Sussex and The POWER: Coastal Communities, directly translating research into community health interventions through structured patient-professional partnerships.

Anna Marie Pyleمشاهده پروفایل

استاد

• RNA structure and function
• Large RNA molecules
• RNA remodeling enzymes
• +۶ مورد دیگر

Anna Marie Pyle is a Sterling Professor in the Departments of Molecular, Cellular and Developmental Biology and Chemistry at Yale University School of Medicine. She has been a Howard Hughes Medical Institute Investigator since 1997 and was elected to the National Academy of Sciences in 2023. Dr. Pyle serves as President of the RNA Society and holds leadership positions at Brookhaven National Labs and the Telluride Science Research Center. Her research focuses on the structure and function of large RNA molecules, RNA remodeling enzymes, and cellular RNA sensors. The Pyle Lab uses a combination of structural biology, enzymology, and cell-based functional approaches to understand RNA architecture and its impact on cellular processes. Current research directions include studying group II introns and other large RNA tertiary structures, protein machines that interact with RNA genes, RNA-virus interactions, and developing RNA-targeting therapeutics. Dr. Pyle's recent publications (2024-2025) demonstrate continued productivity across multiple intersecting fields including RNA structure, viral genomics, immunology, and therapeutic development. Her work has resulted in the development of important research tools including MarathonRT (an ultraprocessive reverse transcriptase) and Stem Loop RNAs (SLRs) for immune activation. Notable Awards and Recognitions: Sterling Professor at Yale University Howard Hughes Medical Institute Investigator (since 1997) Elected to National Academy of Sciences (2023) President of the RNA Society Dr. Pyle mentors students through Yale's undergraduate Molecular Biology course and has trained more than 40 graduate students and postdocs throughout her career. Her lab maintains active collaborations with researchers across Yale and has developed multiple spin-off technologies including RNAConnect and RIGImmune. The lab has access to Yale's extensive research core facilities and maintains strong funding through multiple sources including HHMI and NIH grants. The Pyle Lab is located in Yale's award-winning Science Building on Science Hill and maintains an active research program that bridges fundamental RNA biology with therapeutic applications. Current projects focus on RNA structure, viral pathogenesis, and immune activation through RNA-based approaches.

• Immunology
• Microbiology
• Virology
• +۷ مورد دیگر

Maria Issagouliantis serves as both Associate Professor of Immunology at Karolinska Institutet (since 2007) and Coordinator of Joint Operational Support (since 2024). Her dual roles bridge academic research with administrative leadership in research support services at one of Europe's premier medical universities. Dr. Issagouliantis's research focuses on the complex interplay between viral infections and cancer development, with particular expertise in HIV and HPV virology. Her work examines how viral proteins like reverse transcriptase and protease influence tumor progression through mechanisms including oxidative stress, metabolic reprogramming, and epithelial-mesenchymal transition. She has made significant contributions to DNA vaccine development, particularly for targeting drug-resistant viral variants. Analysis of her recent publications (2020-2024) reveals a consistent focus on viral carcinogenesis mechanisms, with increasing attention to translational applications of immunization strategies. Her work spans basic molecular mechanisms to clinical epidemiology, with notable studies on HPV-HIV co-infections in cancer development and the application of novel vaccine platforms including mRNA technologies. Dr. Issagouliantis maintains active research collaborations across international boundaries, with co-authorship on studies involving institutions in Europe, Russia, and the United States. Her leadership in the Grants Office suggests strong involvement in research administration and funding acquisition, though specific grant details aren't provided in the available information. Her laboratory work, while not formally named in the available information, appears to focus on viral immunology and carcinogenesis, utilizing both in vitro and in vivo models to study viral protein effects on cellular processes and immune responses. The extensive publication record demonstrates a productive research environment with consistent output across multiple virology and immunology journals.